Company Description Affinium is a pharmaceutical company focused on the clinical development of antibacterials. Our lead development program encompasses a potent, orally available, novel antibiotic class for the treatment of antibiotic resistant staphylococcal infections.
Proceeds Purposes This financing will fully fund Affinium’s next two key development goals, the completion of a phase 2 trial for our oral tablet and phase 1 trials of our new IV formulations.